Skip to main content

Advertisement

Log in

18F-FDG PET successfully detects spinal cord sarcoidosis

  • Letter to the editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Though there has been an array of methods to evaluate the extent of sarcoidosis, it is generally difficult to detect central nervous system involvement. Recently it has become accepted that 18F-FDG PET is more sensitive than gallium scintigraphy in finding sarcoid lesions, however its usefulness and limitations for detecting sarcoidosis in the central nervous system, especially in the spinal cord, has rarely been investigated. Two patients with pathologically confirmed sarcoidosis manifested spinal symptoms. We conducted 18F-FDG PET along with conventional imagings before and after treatment. Abnormal FDG uptakes which could not be detected by gallium scintigraphy were shown in the spinal cords in both patients. These abnormal uptakes were diminished in accordance with clinical improvement after treatment. Our findings suggest that 18F-FDG PET is effective in detecting and tracking the activity of spinal sarcoidosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Abbreviations

18F-FDG:

18F-Fluorodeoxyglucose

PET:

Positron emission tomography

CNS:

Central nervous system

MRI:

Magnetic resonance imaging

CSF:

Cerebrospinal fluid

MS:

Multiple sclerosis

BBB:

Blood brain barrier

References

  1. Hoitsma E, Faber CG, Drent M, Sharma OP (2004) Neurosarcoidosis: a clinical dilemma. Lancet Neurol 3:397–407

    Article  PubMed  Google Scholar 

  2. Zajicek JP, Scolding NJ, Foster O, Rovaris M, Evanson J, Moseley IF, Scadding JW, Thompson EJ, Chamoun V, Miller DH, McDonald WI, Mitchell D (1999) Central nervous system sarcoidosis-diagnosis and management. QJM 92:103–117

    Article  CAS  PubMed  Google Scholar 

  3. Saleh S, Saw C, Marzouk K, Sharma O (2006) Sarcoidosis of the spinal cord: literature review and report of eight cases. J Natl Med Assoc 98:965–976

    PubMed  Google Scholar 

  4. Sulavik SB, Spencer RP, Weed DA, Shapiro HR, Shiue ST, Castriotta RJ (1990) Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis. J Nucl Med 31:1909–1914

    CAS  PubMed  Google Scholar 

  5. Larson SM, Milder MS, Johnston GS (1972) Interpretation of the 67 Ga photoscan. J Nucl Med 14:208–214

    Google Scholar 

  6. Pickuth D, Heywang-Köbrunner SH (2000) Neurosarcoidosis: evaluation with MRI. J Neuroradiol 27:185–188

    CAS  PubMed  Google Scholar 

  7. Rohren EM, Turkington TG, Coleman RE (2004) Clinical applications of PET in oncology. Radiology 231:305–332

    Article  PubMed  Google Scholar 

  8. Omuro AM, Leite CC, Mokhtari K, Delattre JY (2006) Pitfalls in the diagnosis of brain tumours. Lancet Neurol 5:937–948

    Article  PubMed  Google Scholar 

  9. Nishiyama Y, Yamamoto Y, Fukunaga K, Takinami H, Iwado Y, Satoh K, Ohkawa M (2006) Comparative evaluation of 18F-FDG PET and 67 Ga scintigraphy in patients with sarcoidosis. J Nucl Med 47:1571–1576

    PubMed  Google Scholar 

  10. Xiu Y, Yu JQ, Cheng E, Kumar R, Alavi A, Zhuang H (2005) Sarcoidosis demonstrated by FDG PET imaging with negative findings on gallium scintigraphy. Clin Nucl Med 30:193–195

    Article  PubMed  Google Scholar 

  11. Aide N, Benayoun M, Kerrou K, Khalil A, Cadranel J, Talbot JN (2007) Impact of [18F]-fluorodeoxyglucose([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy. Br J Radiol 80:e67–e71

    Article  CAS  PubMed  Google Scholar 

  12. Dubey N, Miletich RS, Wasay M, Mechtler LL, Bakshi R (2002) Role of fluorodeoxyglucose positron emission tomography in the diagnosis of neurosarcoidosis. J Neurol Sci 205:77–81

    Article  PubMed  Google Scholar 

  13. Spencer TS, Campellone JV, Maldonado I, Huang N, Usmani Q, Reginato AJ (2005) Clinical and magnetic resonance imaging manifestations of neurosarcoidosis. Semin Arthritis Rheum 34:649–661

    Article  PubMed  Google Scholar 

  14. Baron EM, Young WF (2007) Cervical spondylotic myelopathy: a brief review of its pathophysiology, clinical course, and diagnosis. Neurosurgery 60:35–41

    Article  Google Scholar 

  15. Cohen PR, Kurzrock R (2007) Sarcoidosis and malignancy. Clin Dermatol 25:326–333

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

We thank Kathryn Soriano for proofreading our manuscript and providing meaningful advice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Taiji Tsunemi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ota, K., Tsunemi, T., Saito, K. et al. 18F-FDG PET successfully detects spinal cord sarcoidosis. J Neurol 256, 1943–1946 (2009). https://doi.org/10.1007/s00415-009-5270-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-009-5270-8

Keywords

Navigation